Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Eva Perez Pampin"'
Autor:
Lorena Rodriguez-Martinez, Cristina García-Moreno, Eva Perez-Pampin, María J. Gómara, Juan C. Sarmiento-Monroy, Yolanda Lopez-Golán, José A. Gómez-Puerta, Antonio Mera-Varela, Carmen Conde, Raimon Sanmartí, Isabel Haro, Antonio González
Publikováno v:
Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-14 (2023)
Abstract Background Autoantibodies are critical elements in RA pathogenesis and clinical assessment. The anti-malondialdehyde-acetaldehyde (anti-MAA) antibodies are potentially useful because of their claimed high sensitivity for all RA patients, inc
Externí odkaz:
https://doaj.org/article/fe7bfc8d419849f68d300c670efe5da0
Autor:
Juan José Bethencourt Baute, Carlos Sanchez-Piedra, Dolores Ruiz-Montesinos, Marta Medrano San Ildefonso, Carlos Rodriguez-Lozano, Eva Perez-Pampin, Ana Ortiz, Sara Manrique, Rosa Roselló, Victoria Hernandez, Cristina Campos, Agustí Sellas, Walter Alberto Sifuentes-Giraldo, Javier García-González, Fernando Sanchez-Alonso, Federico Díaz-González, Juan Jesús Gómez-Reino, Sagrario Bustabad Reyes, on behalf of the BIOBADASER study group
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-9 (2018)
Abstract Background Biologic therapy has changed the prognosis of patients with juvenile idiopathic arthritis (JIA). The aim of this study was to examine the pattern of use, drug survival, and adverse events of biologics in patients with JIA during t
Externí odkaz:
https://doaj.org/article/f0d35832bc814a5898b44ebb28ac5c51
Autor:
Aida Ferreiro-Iglesias, Ariana Montes, Eva Perez-Pampin, Juan D Cañete, Enrique Raya, Cesar Magro-Checa, Yiannis Vasilopoulos, Rafael Caliz, Miguel Angel Ferrer, Beatriz Joven, Patricia Carreira, Alejandro Balsa, Dora Pascual-Salcedo, Francisco J Blanco, Manuel J Moreno-Ramos, Sara Manrique-Arija, María Del Carmen Ordoñez, Juan Jose Alegre-Sancho, Javier Narvaez, Federico Navarro-Sarabia, Virginia Moreira, Lara Valor, Rosa Garcia-Portales, Ana Marquez, Juan J Gomez-Reino, Javier Martin, Antonio Gonzalez
Publikováno v:
PLoS ONE, Vol 14, Iss 2, p e0213073 (2019)
Research in rheumatoid arthritis (RA) is increasingly focused on the discovery of biomarkers that could enable personalized treatments. The genetic biomarkers associated with the response to TNF inhibitors (TNFi) are among the most studied. They incl
Externí odkaz:
https://doaj.org/article/63ceff512b484958947a7084dbdd2f7e
Autor:
Fernando Gomollón, Daniel Seoane-Mato, Miguel A. Montoro, Xavier Juanola, Elisa Trujillo-Martin, Marta Carrillo-Palau, Virginia Matallana, Blanca García-Magallón, Yolanda Ber, Laura Ramos, Eva Perez-Pampin, Rocío Ferreiro-Iglesias, Lorena Rodríguez-Alonso, Carla Marco-Pascual, Jesús Sanz Sanz
Publikováno v:
Digestive and Liver Disease. 54:755-762
Spondyloarthritis (SpA) is one of the most common extraintestinal manifestations of inflammatory bowel disease (IBD). Diagnostic delay must be avoided.We assessed the validity of SpA screening criteria (any of the following characteristics: chronic l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17c39a53640ccd2bb7b5a43a47adc645
https://doi.org/10.1016/j.dld.2021.12.010
https://doi.org/10.1016/j.dld.2021.12.010
Autor:
Rosario Lopez-Rodriguez, Eva Perez-Pampin, Ana Marquez, Francisco J Blanco, Beatriz Joven, Patricia Carreira, Miguel Angel Ferrer, Rafael Caliz, Lara Valor, Javier Narvaez, Juan D Cañete, Maria Del Carmen Ordoñez, Sara Manrique-Arija, Yiannis Vasilopoulos, Alejandro Balsa, Dora Pascual-Salcedo, Manuel J Moreno-Ramos, Juan Jose Alegre-Sancho, Federico Navarro-Sarabia, Virginia Moreira, Rosa Garcia-Portales, Enrique Raya, Cesar Magro-Checa, Javier Martin, Juan J Gomez-Reino, Antonio Gonzalez
Publikováno v:
PLoS ONE, Vol 13, Iss 5, p e0196793 (2018)
Genetic biomarkers are sought to personalize treatment of patients with rheumatoid arthritis (RA), given their variable response to TNF inhibitors (TNFi). However, no genetic biomaker is yet sufficiently validated. Here, we report a validation study
Externí odkaz:
https://doaj.org/article/81eb385d7e2649958830718e9afb63b9
Autor:
Laura Vidal-Bralo, Eva Perez-Pampin, Cristina Regueiro, Ariana Montes, Rosana Varela, Maria Dolores Boveda, Juan J Gomez-Reino, Antonio Gonzalez
Publikováno v:
PLoS ONE, Vol 12, Iss 7, p e0180144 (2017)
Patients with rheumatoid arthritis (RA) have an increased mortality rate that is associated with the presence of RA-specific autoantibodies in many studies. However, the relative role of rheumatoid factor (RF), anti-CCP antibodies and the most recent
Externí odkaz:
https://doaj.org/article/364af557af734ea4923e2e5a99db84b5
Autor:
Ariana Montes, Cristina Regueiro, Eva Perez-Pampin, Maria Dolores Boveda, Juan J Gomez-Reino, Antonio Gonzalez
Publikováno v:
PLoS ONE, Vol 11, Iss 8, p e0161141 (2016)
A large fraction of the patients with rheumatoid arthritis (RA) develop specific autoantibodies, which until recently were only of two types, rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA). We aimed to replicate important fin
Externí odkaz:
https://doaj.org/article/b88cd1f51d4c491d83a268c6377d0766
Autor:
Lucía Lourido, Cristina Regueiro, Naomi Diz-Rosales, Cristina Ruiz-Romero, José Antonio Pinto Tasende, Antonio Mera-Varela, K. Hambardzumyan, Sergio Vilaboa-Galán, Eva Perez-Pampin, Saedis Saevarsdottir, Flor Picchi, Antonio Gonzalez, Francisco J. Blanco, Peter Nilsson, Carlos Fernández-López
Publikováno v:
RUC: Repositorio da Universidade da Coruña
Universidade da Coruña (UDC)
RUC. Repositorio da Universidade da Coruña
instname
Universidade da Coruña (UDC)
RUC. Repositorio da Universidade da Coruña
instname
[Abstract] Background: One-third of rheumatoid arthritis (RA) patients demonstrate no clinical improvement after receiving tumor necrosis factor inhibitors (TNFi). The presence of serum autoantibodies is a hallmark in RA and may provide information o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83ecbaba7bbe87e20fc35427ae23c717
https://doi.org/10.1016/j.semarthrit.2020.06.010
https://doi.org/10.1016/j.semarthrit.2020.06.010
Autor:
Eduardo Cuende, M. Victoria Hernández Miguel, Raquel Martín Domenech, Rosa Roselló, Jesús T. Sánchez-Costa, Carlos Sánchez-Piedra, Javier del Pino-Montes, Jesús Carlos Fernández-Lopez, Carlos Rodríguez-Lozano, Ana Milena Millan-Arciniegas, Javier Manero, Eva Perez-Pampin, en representación del Grupo de trabajo Biobadaser Fase, Juan J. Gomez-Reino, Sagrario Bustabad, Federico Díaz-González, Cristina Campos
Publikováno v:
Reumatología Clínica. 15:229-236
Objective Describe the objectives, methods and results of the first year of the new version of the Spanish registry of adverse events involving biological therapies and synthetic drugs with an identifiable target in rheumatic diseases (BIOBADASER III
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2af93ac61953c02a7f7ee7d34b76908
https://doi.org/10.1016/j.reuma.2017.08.001
https://doi.org/10.1016/j.reuma.2017.08.001
Autor:
Antonio Mera-Varela, Aida Ferreiro-Iglesias, Eva Perez-Pampin, Marisol Porto-Silva, Juan J Gómez-Reino, Antonio Gonzalez
Publikováno v:
PLoS ONE, Vol 8, Iss 3, p e58616 (2013)
INTRODUCTION: HLA-B27 has a modifier effect on the phenotype of multiple diseases, both associated and non-associated with it. Among these effects, an increased frequency of clinical enthesitis in patients with Rheumatoid Arthritis (RA) has been repo
Externí odkaz:
https://doaj.org/article/8ea55ab98d424b899d5b9da198c3ec52